• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association between control of cardiovascular risk factors and acute myocardial infarction among re-hospitalized young patients with prior coronary heart disease.

作者信息

Yang Hongxia, Zuo Huijuan, Wu Xiaofan, Jia Shujie, Song Xiantao

机构信息

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Department of Community Health Research, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

出版信息

Chin Med J (Engl). 2023 Jun 5;136(11):1364-1366. doi: 10.1097/CM9.0000000000002173.

DOI:10.1097/CM9.0000000000002173
PMID:37160735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10309500/
Abstract
摘要

相似文献

1
Association between control of cardiovascular risk factors and acute myocardial infarction among re-hospitalized young patients with prior coronary heart disease.
Chin Med J (Engl). 2023 Jun 5;136(11):1364-1366. doi: 10.1097/CM9.0000000000002173.
2
Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD).老年急性心肌梗死合并非酒精性脂肪肝患者不良心血管事件的危险因素分析。
Med Sci Monit. 2020 Jun 1;26:e922913. doi: 10.12659/MSM.922913.
3
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.心肌再灌注可逆转心肌梗死后左心室功能不全和心力衰竭患者心血管风险与舒张压之间的J曲线关联：来自EPHESUS试验的见解。
Eur Heart J. 2020 May 1;41(17):1673-1683. doi: 10.1093/eurheartj/ehaa132.
4
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.首次心肌梗死患者的冠心病危险因素数量与死亡率。
JAMA. 2011 Nov 16;306(19):2120-7. doi: 10.1001/jama.2011.1654.
5
Diagnosable coronary heart disease. III. Unusual aspects or complications of myocardial infarction.
Northwest Med. 1956 Jan;55(1):63-4.
6
Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway.甲状腺功能与冠心病风险：挪威 HUNT 研究 12 年随访。
Clin Endocrinol (Oxf). 2012 Dec;77(6):911-7. doi: 10.1111/j.1365-2265.2012.04477.x.
7
Serum Aldosterone as Predictor of Progression of Coronary Heart Disease in Patients Without Signs of Heart Failure After Acute Myocardial Infarction.血清醛固酮作为急性心肌梗死后无心力衰竭迹象患者冠心病进展的预测指标
Med Arch. 2018 Dec;72(6):406-409. doi: 10.5455/medarh.2018.72.406-409.
8
ESC Population Studies Lecture 1996. Cardiovascular monitoring of a city over 30 years.1996年欧洲心脏病学会人群研究讲座。对一个城市30多年来的心血管监测。
Eur Heart J. 1997 Aug;18(8):1220-30. doi: 10.1093/oxfordjournals.eurheartj.a015433.
9
Acquired left ventricular to coronary sinus fistula: an unusual complication of acute myocardial infarction.
Ann Thorac Surg. 1987 Nov;44(5):550-1. doi: 10.1016/s0003-4975(10)62124-8.
10
Myocardial infarction and/or fatal coronary disease in young soldiers.
J Iowa State Med Soc. 1947 Feb;37(2):56-64.

引用本文的文献

1
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases.仿生细胞膜包覆纳米载体在心血管疾病中的应用
Int J Nanomedicine. 2025 Jun 26;20:8249-8289. doi: 10.2147/IJN.S531558. eCollection 2025.
2
Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.生物膜修饰仿生纳米药物递送系统：心血管疾病治疗的前沿平台。
Biomolecules. 2024 Aug 7;14(8):960. doi: 10.3390/biom14080960.
3
Evaluating Long-Term Outcomes in STEMI Patients with New Left Bundle Branch Block: The Impact of Modifiable Risk Factors.评估新发左束支传导阻滞的ST段抬高型心肌梗死患者的长期预后：可改变危险因素的影响
J Pers Med. 2024 Jul 19;14(7):771. doi: 10.3390/jpm14070771.